COVID-19 Vaccine Development

A SARS-CoV-2 vaccine would be a very powerful tool to slow down the COVID-19 pandemic. Well over a hundred vaccine candidates are in development, with some already being tested for safety and efficacy, or in phase I clinical trials. This feed follows the latest studies on vaccine design and development.

January 14, 2021

COVID-19 vaccine: where are we now and where should we go?

Expert Review of Vaccines
Saman Soleimanpour, Atieh Yaghoubi
January 15, 2021

COVID-19 vaccine testing in pregnant females is necessary

The Journal of Clinical Investigation
Sabra L KleinIrina Burd
January 15, 2021
Preprint
Open Access

The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

BioRxiv : the Preprint Server for Biology
Dapeng LiKevin O Saunders
January 19, 2021
Review
Open Access

Review of pharmacologic and immunologic agents in the management of COVID-19

Biosafety and Health
Marzuq A UngogoGarba M Khalid
January 20, 2021
Open Access

Using COVID-19 as a teaching tool in a time of remote learning: A workflow for bioinformatic approaches to identifying candidates for therapeutic and vaccine development

Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology
Samantha BryceReeta P Rao
January 13, 2021
Open Access

Vaccinology in the post-COVID-19 era

Proceedings of the National Academy of Sciences of the United States of America
Rino RappuoliEmmanuel Hanon
January 10, 2021
Open Access

Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Jnanendra Prasad SarkarUjjwal Maulik
January 19, 2021
Preprint
Open Access

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine

BioRxiv : the Preprint Server for Biology
W. FuruyamaAndrea Marzi
January 13, 2021
Open Access

A call to action: why medical education curriculum needs to encourage young physicians to innovate

Archives of Dermatological Research
Aditi A SharmaLilit Garibyan
January 12, 2021
Review
Open Access

A review of COVID-19 vaccines in development: 6 months into the pandemic

The Pan African Medical Journal
Merlin SanicasEmanuele Montomoli
January 19, 2021
Review

Potential health benefits of zinc supplementation for the management of COVID-19 pandemic

Journal of Food Biochemistry
Ademola Adetokunbo OyagbemiMomoh Audu Yakubu
January 11, 2021
Open Access

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice

EBioMedicine
Katharina WørznerGabriel Kristian Pedersen
January 9, 2021
Preprint
Open Access

The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout

MedRxiv : the Preprint Server for Health Sciences
N. GozziN. Perra
January 15, 2021
Preprint
Open Access

Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates

BioRxiv : the Preprint Server for Biology
Nerea ZabaletaLuk H Vandenberghe
January 20, 2021
Preprint
Open Access

Immunisation, asymptomatic infection, herd immunity and the new variants of COVID-19

MedRxiv : the Preprint Server for Health Sciences
Alastair Grant, P. R. Hunter
January 15, 2021
Preprint
Open Access

The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation

MedRxiv : the Preprint Server for Health Sciences
Mehul D PatelJulie L Swann

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

© 2021 Meta ULC. All rights reserved
/feed-previews/covid-19-vaccine-development/6282cef3-6d29-4262-ad8a-a937a12a89f9